Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed route for high-purity deuterated intermediates. Cost-effective, scalable manufacturing for pharmaceutical applications using aryl sulfur salts.
Patent CN111187184A reveals a green Pd-catalyzed route using CO and sulfonyl azides, offering high yields and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN106349150B reveals efficient Pd-catalyzed carbonylation. Enables cost reduction in API intermediate manufacturing with high purity and scalable processes for global supply chains.
Patent CN108558753A details a mild quinolone synthesis method using iron pentacarbonyl. This approach offers significant supply chain safety and cost reduction advantages for pharmaceutical intermediates manufacturing.
Patent CN110204489B reveals a safe, one-pot quinolone synthesis using solid chromium hexacarbonyl. Discover cost-effective manufacturing and scalable supply solutions.
Novel Pd-catalyzed synthesis avoids toxic CO gas usage. High yield 77%. Reliable supply chain for sulfur-containing heterocycles and pharmaceutical intermediates manufacturing.
Patent CN116003360A details a green Pd-catalyzed synthesis of aurones using CO2 and alkynes, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107629051B reveals a novel three-step carbonylation route for evodiamine, offering streamlined production and cost advantages for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for alpha,beta-unsaturated carbonyls. High yield, mild conditions, scalable for pharmaceutical supply chains.
This report analyzes patent CN109761882A for Carprofen synthesis offering significant supply chain stability and cost reduction benefits for global veterinary pharmaceutical manufacturers.
Novel mild route for APJ agonist intermediate. Optimized bromination and Pd-catalyzed carbonylation ensure stable supply and cost efficiency.
Novel palladium-catalyzed method for sulfonylureas eliminates phosgene risks. Cost-effective scalable manufacturing for pharmaceutical intermediates ensuring supply chain reliability and high purity.
Patent CN105001216B reveals a one-step quinazinone preparation method. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114213272B details a novel copper-catalyzed carbonylation method for arylethynyl formamides, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Pd-catalyzed pathway reduces costs for chroman amides. Enhances supply chain stability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed synthesis method for isoquinoline ketones offering high efficiency and substrate compatibility for pharmaceutical intermediate manufacturing supply chains.
Novel Pd-catalyzed multicomponent route for indolinone-imidazole scaffolds offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN113045503A reveals a novel palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel palladium-catalyzed carbonylation method enhances purity and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.